Life Sciences, Pharmaceutical, Medical Device, and BioTech

Clinical Research Execution Aligned With Global Trial Equity Standards

Precision HealthCare Consultants is a global healthcare advisory and clinical research support partner to pharmaceutical, biotechnology, medical device companies, and CROs operating across the United States, Africa, Asia, with active expansion underway across the Middle East and other emerging global markets.

Our work is grounded in the principles outlined by the U.S. Food and Drug Administration and the International Council for Harmonisation—supporting clinical trials that are inclusive, representative, ethical, and reflective of real-world patient populations.

We help life sciences organizations translate global trial equity guidance into practical, compliant, and executable solutions, particularly in regions and communities that have historically been underrepresented in clinical research.

Pilot-First Clinical Trial Support That Reduces Risk and Builds Evidence

Precision specializes in pilot-based engagements that allow sponsors and CROs to operationalize inclusive trial strategies before scaling globally.

Our pilots support:

  • Enrollment strategies aligned with FDA guidance on enhancing participation
  • Community-based recruitment models consistent with ICH GCP principles
  • Protocol-specific enrollment recovery and feasibility testing
  • Site readiness across mature and emerging research markets
  • Early real-world insights to inform regional and global trial expansion


Each pilot is time-bound, milestone-driven, and outcomes-focused, enabling organizations to validate approaches while maintaining regulatory rigor.

CRO Support Built for Compliance and Real-World Delivery

Precision works as a trusted extension of CRO and sponsor teams, strengthening trial delivery while reinforcing compliance with ICH E6 (GCP) and evolving global regulatory expectations.

We provide CRO-aligned support across:

  • Patient recruitment and retention execution
  • Community-based site engagement and activation
  • Chart reviews, data abstraction, and documentation support
  • Study operations, monitoring assistance, and quality oversight
  • Enrollment analytics and real-world data insights


Our teams integrate seamlessly into existing trial infrastructures—supporting delivery across diverse geographies without adding complexity.

Advancing Trial Equity in Forgotten Communities Worldwide

Global trial guidance consistently emphasizes that equity requires early, sustained, and ethical engagement—especially in communities where trust, access, and awareness have been limited.

Precision specializes in engaging forgotten communities across:

  • Underserved urban and rural populations in the U.S.
  • Community-based healthcare networks in Africa and Asia
  • Emerging research environments in the Middle East
  • Regions historically excluded from global clinical research


We partner with clinics, community organizations, patient advocates, and local leaders to support culturally responsive outreach, ethical participation, and sustained engagement—driving stronger enrollment, improved retention, and more representative data.

Global Trials, Locally Executed

Precision operates across 39 U.S. states, multiple countries in Africa and Asia, and three continents, with continued expansion into the Middle East and emerging global markets.

We help sponsors and CROs:

  • Localize global trial strategies while maintaining regulatory consistency
  • Navigate cultural, operational, and infrastructure considerations
  • Build sustainable clinical research capacity in new regions
  • Align global objectives with local execution and community trust


Our model ensures trials are both globally compliant and locally credible.

Why Life Sciences Organizations Choose Precision

  • Alignment with FDA and ICH global trial equity guidance
  • Pilot-first approach that reduces risk and accelerates learning
  • Trusted access to historically underrepresented populations
  • Seamless CRO and sponsor team integration
  • Experience operating across mature and emerging markets
  • Measurable outcomes with accountability

Life Sciences at a Glance

Who We Support
Pharma • Biotech • Medical Device • CROs • Research Sponsors

What We Deliver
Clinical trial support • Inclusive patient recruitment • Community engagement • CRO enablement • Data & documentation support

Where We Operate
United States • Africa • Asia • Expanding across the Middle East & emerging markets

How We Engage
Pilot-based • Compliant • Outcomes-driven

Precision HealthCare Life Sciences

How do pharmaceutical companies reach underserved populations when those populations don’t trust big pharma? We know a thing or two about that. When the CDC needs services mobilized during a pandemic, how about putting boots on the ground from Asia to Africa? Experts equipped with culturally relevant materials, effective outreach, starts with understanding. When an STI is on the rise, how about reaching beyond the university’s clinical sites to find patients that are resistant to conventional treatment? Innovation in medicine means finding solutions where they’re needed most. When a university asks to identify optimal clinic locations and healthcare deserts, how about deploying teams who speak the native languages? Teams who know the nuances of these communities because they’re a part of these communities. You may not have that reach, but we do. These are the stories of some of our own success. We don’t just call it strategy, we call it humanity. Communities trust us because we are not outsiders. We live and work among them. We build relationships, not transactions. Remember, those who are strangers to some are neighbors to others. When populations seem unreachable, partner with a team that’s already there.

Start With a Pilot. Scale Equitable Trials Globally.

Whether launching a new study, recovering enrollment, expanding into Africa, Asia, or the Middle East, or strengthening global trial equity strategies, Precision helps life sciences organizations move from guidance to execution—responsibly, compliantly, and with impact.

Let’s explore a pilot aligned to your protocol, population, and region.